Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial.
- 2026-01
- RCT
- The journal of prevention of Alzheimer's disease 13(1)
- Yinyue Liu
- Zili Yu
- Zhengjun Cai
- Li Zhao
- Yu Wang
- Yajie Guo
- Xiaonan Su
- Yuli Miao
- Bin Yi
- Yanhong Wang
- Xumei Zhang
- PubMed: 40945966
- DOI: 10.1016/j.tjpad.2025.100369
- High evidence
- Clinical
MoCA and MMSE scores improved significantly in the FA group compared to placebo (both P < 0.05).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 0.4 mg/tablet, two tablets daily